Alivus Life Sciences to announce financial results in November

Alivus Life Sciences Limited, formerly Glenmark Life Sciences Limited, has announced a Board of Directors meeting for Thursday, November 6, 2025. The meeting's primary agenda is to consider and approve the unaudited financial results for the quarter and half-year period ending September 30, 2025.

In accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, the company has closed its trading window for 'designated persons'. This window closed on September 30, 2025, and will reopen on November 8, 2025, to facilitate the approval of the financial results.

The announcement, dated October 29, 2025, was issued by rudalf corriea, company secretary & compliance officer. The company's corporate office is in Mumbai, with its registered office in Solapur.